Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1984 1
1989 1
1992 1
1995 1
1999 3
2001 1
2002 3
2003 11
2004 9
2005 6
2006 13
2007 10
2008 16
2009 8
2010 13
2011 10
2012 9
2013 15
2014 13
2015 9
2016 14
2017 20
2018 16
2019 12
2020 14
2021 15
2022 20
2023 31
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

288 results

Results by year

Filters applied: . Clear all
Page 1
Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.
Shen R, Fu D, Dong L, Zhang MC, Shi Q, Shi ZY, Cheng S, Wang L, Xu PP, Zhao WL. Shen R, et al. Among authors: zhang mc. Signal Transduct Target Ther. 2023 Apr 10;8(1):145. doi: 10.1038/s41392-023-01358-y. Signal Transduct Target Ther. 2023. PMID: 37032379 Free PMC article.
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression.
Geng C, Zhang MC, Manyam GC, Vykoukal JV, Fahrmann JF, Peng S, Wu C, Park S, Kondraganti S, Wang D, Robinson BD, Loda M, Barbieri CE, Yap TA, Corn PG, Hanash S, Broom BM, Pilié PG, Thompson TC. Geng C, et al. Among authors: zhang mc. Clin Cancer Res. 2023 Nov 1;29(21):4464-4478. doi: 10.1158/1078-0432.CCR-23-1439. Clin Cancer Res. 2023. PMID: 37581614
A phosphoglycerate mutase 1 allosteric inhibitor overcomes drug resistance to EGFR-targeted therapy via disrupting IL-6/JAK2/STAT3 signaling pathway in lung adenocarcinoma.
Liang Q, Gong M, Zou JH, Luo MY, Jiang LL, Wang C, Shen NX, Zhang MC, Xu L, Lei HM, Zhang KR, Zhang R, Zhuang G, Zhu L, Chen HZ, Zhou L, Shen Y. Liang Q, et al. Among authors: zhang mc. Drug Resist Updat. 2023 May;68:100957. doi: 10.1016/j.drup.2023.100957. Epub 2023 Mar 16. Drug Resist Updat. 2023. PMID: 36990047 Free article.
Asymmetric C3-Allylation of Pyridines.
Liu Z, Shi ZJ, Liu L, Zhang M, Zhang MC, Guo HY, Wang XC. Liu Z, et al. Among authors: zhang mc. J Am Chem Soc. 2023 May 31;145(21):11789-11797. doi: 10.1021/jacs.3c03056. Epub 2023 May 17. J Am Chem Soc. 2023. PMID: 37198745
Evidence of SARS-CoV-2 Transmission Through the Ocular Route.
Qu JY, Xie HT, Zhang MC. Qu JY, et al. Among authors: zhang mc. Clin Ophthalmol. 2021 Feb 18;15:687-696. doi: 10.2147/OPTH.S295283. eCollection 2021. Clin Ophthalmol. 2021. PMID: 33658750 Free PMC article. Review.
Progress in salivary glands: Endocrine glands with immune functions.
Shang YF, Shen YY, Zhang MC, Lv MC, Wang TY, Chen XQ, Lin J. Shang YF, et al. Among authors: zhang mc. Front Endocrinol (Lausanne). 2023 Feb 3;14:1061235. doi: 10.3389/fendo.2023.1061235. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36817607 Free PMC article. Review.
Functional Diversity of p53 in Human and Wild Animals.
Li Y, Zhang MC, Xu XK, Zhao Y, Mahanand C, Zhu T, Deng H, Nevo E, Du JZ, Chen XQ. Li Y, et al. Among authors: zhang mc. Front Endocrinol (Lausanne). 2019 Mar 12;10:152. doi: 10.3389/fendo.2019.00152. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 30915036 Free PMC article. Review.
288 results